Publications by authors named "Miyabi Uda"
Background: The management of anxiety and depression symptoms in rheumatoid arthritis (RA) patients is vital. Previous study findings on this topic are conflicting, and the topic remains to be thoroughly investigated. This study aimed to clarify the association of RA disease activity with anxiety and depression symptoms after controlling for physical disability, pain, and medication.
View Article and Find Full Text PDFArticle Synopsis
- This study investigates the link between mental disorders (depression and anxiety) and dietary habits in female rheumatoid arthritis (RA) patients, as mental health significantly affects RA remission rates.
- A cross-sectional study involving 267 participants utilized questionnaires to compare depression states and dietary intake, focusing on specific foods like fish, vegetables, and fruits.
- Results showed that higher depression and anxiety scores were associated with lower consumption of these foods, particularly fish, and indicated that frequent fish intake was linked to better mental health outcomes in RA patients.
Effect of Physical State on Pain Mediated Through Emotional Health in Rheumatoid Arthritis.
Arthritis Care Res (Hoboken)
September 2019
Objective: Pain is one of the main symptoms of patients with rheumatoid arthritis (RA). Pain in RA is caused by specific physical changes, such as joint destruction, and is therefore used as a disease activity marker. Although pain can also be influenced by emotional factors, neither the effect of emotional health nor the indirect effect of the physical state mediated by emotional health on pain has been quantified.
View Article and Find Full Text PDFArticle Synopsis
- * It involved 388 patients and assessed their muscle mass, strength, walking speed, and history of falls and fractures, revealing higher risks of falls and fractures in those with sarcopenia.
- * Key factors linked to sarcopenia included age, duration of RA, stage of RA, nutritional status, and the use of biological disease-modifying anti-rheumatic drugs (bDMARDs), with longer disease duration and malnutrition increasing sarcopenia risk.